New Brunswick, New Jersey
Phase 2 colorectal cancer trials in New Brunswick, NJ
6 Phase 2 colorectal cancer studies are recruiting participants at sites in New Brunswick as of November 18, 2026, according to ClinicalTrials.gov. Colorectal Phase 2 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
New Brunswick at a glance
- 6 studies are recruiting at a site in New Brunswick.
- By phase: Phase 2 (6).
- By sponsor: university, hospital or other (4), industry (2).
- Most recent update to one of these records: November 5, 2026.
Studies recruiting in New Brunswick
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Dustin Deming
- Study site
- Rutgers Cancer Institute of New Jersey
- Registry record
- NCT06493019 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Study site
- Rutgers Cancer Institute
- Registry record
- NCT07446322 · updated
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Christian Hinrichs
- Study sites
- RWJBarnabas Health - Robert Wood Johnson University Hospital · Rutgers Cancer Institute
- Registry record
- NCT05686226 · updated
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Criterium, Inc.
- Study site
- Rutgers Cancer Institute
- Registry record
- NCT06992258 · updated
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Rutgers, The State University of New Jersey
- Study sites
- RWJBarnabas Health - Robert Wood Johnson University Hospital · Rutgers Cancer Institute of New Jersey
- Registry record
- NCT05806931 · updated
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Howard S. Hochster, MD
- Study sites
- Robert Wood Johnson University Hospital · Rutgers Cancer Institute of New Jersey
- Registry record
- NCT05296681 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in New Brunswick, NJ on ClinicalTrials.gov.
Ask about studies near New Brunswick
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in New Jersey
All New Jersey locations
15 studies recruiting across 19 cities.
Basking Ridge
6 studies recruiting.
Middletown
6 studies recruiting.
Montvale
6 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.
Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections